Carotid balloon occlusion for large and giant aneurysms: Evaluation of a new test occlusion protocol

Citation
Wjj. Van Rooij et al., Carotid balloon occlusion for large and giant aneurysms: Evaluation of a new test occlusion protocol, NEUROSURGER, 47(1), 2000, pp. 116-121
Citations number
16
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
NEUROSURGERY
ISSN journal
0148396X → ACNP
Volume
47
Issue
1
Year of publication
2000
Pages
116 - 121
Database
ISI
SICI code
0148-396X(200007)47:1<116:CBOFLA>2.0.ZU;2-6
Abstract
OBJECTIVE: Validation of a new angiographic test occlusion protocol before carotid balloon occlusion in patients with carotid aneurysms. METHODS: Carotid occlusion was considered for 29 consecutive patients. From 1993 to 1995, test occlusion in four patients consisted of clinical observ ation for 30 minutes and during electroencephalographic registration. From 1996 onward, test occlusion in 25 patients consisted of clinical observatio n and angiography of collateral vessels. Permanent balloon occlusion was pe rformed only when the cortical veins in both the occluded and the collatera l vascular territories filled synchronously. RESULTS: Two of the four patients with normal clinical and electroencephalo graphic findings during test occlusion developed delayed hypoperfusion infa rction after permanent carotid occlusion. Seventeen of 25 patients (68%) de monstrated both clinical and angiographic tolerance, and no ischemic events occurred after permanent carotid occlusion. In one patient with clinical t olerance but angiographic nontolerance, permanent carotid occlusion had to be performed, which resulted in delayed hypoperfusion infarction. In two pa tients with angiographic nontolerance, venous filling became synchronous af ter bypass surgery. Long-term clinical follow-up showed an alleviation of t he symptoms of mass effect in 14 of 21 patients (67%). Magnetic resonance i maging follow-up (range, 3-70 mo) revealed a reduction in the size of the a neurysm in 19 of 21 patients (90%). CONCLUSION: Test occlusion with clinical and angiographic control is reliab le, safe, and simple to perform.